BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. BIOLASE’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. BIOLASE is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.

Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1987
Size (employees)
200 (est)
Biolase was founded in 1987 and is headquartered in Irvine, US

Key People at Biolase

Jeffrey Nugent

Jeffrey Nugent

President and Chief Executive Officer
Dmitri Boutoussov

Dmitri Boutoussov

CTO
Frederick D. Furry

Frederick D. Furry

Chief Financial Officer
William E. Brown

William E. Brown

VP, Business Development

Biolase Office Locations

Biolase has offices in Irvine, Miami, Denver, Seattle and in 13 other locations
Irvine, US (HQ)
4 Cromwell

Biolase Metrics

Biolase Financial Metrics

Revenue (2016)

$51.8 m

Revenue growth (2015-16), %

7%

Gross profit

$20.3 m

Gross profit margin (2016), %

39%

Net income (2016)

($15.4 m)

Market capitalization (28-Apr-2017)

$86.5 m

Closing share price (28-Apr-2017)

$1.4

Cash (31-Dec-2016)

$8.9 m
Biolase's current market capitalization is $86.5 m.
Biolase's revenue was reported to be $51.8 m in 2016 which is a 7% increase from the previous period.
FY, 2013Y, 2014Y, 2015Y, 2016

Revenue

$56.4 m$47.7 m$48.5 m$51.8 m

Revenue growth, %

(16%)2%7%

Cost of goods sold

$34.9 m$29.5 m$32.5 m$31.5 m

Gross profit

$21.5 m$18.2 m$16 m$20.3 m

Gross profit Margin, %

38%38%33%39%

Operating expense total

$32.5 m$36.1 m$35.9 m$35.3 m

EBIT

($11 m)($17.9 m)($19.9 m)($15 m)

EBIT margin, %

(19%)(38%)(41%)(29%)

Interest expense

$600 k$458 k$74 k$74 k

Interest income

$74 k$74 k

Income tax expense

($164 k)$112 k$178 k$151 k

Net Income

($11.5 m)($18.9 m)($20.3 m)($15.4 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$1.4 m$31.6 m$11.7 m$8.9 m

Accounts Receivable

Inventories

$1.9 m$1.7 m$1.4 m$1.5 m

Current Assets

$25.9 m$54.8 m$34.8 m$34 m

PP&E

$1.8 m$1.3 m$3.7 m$4.5 m

Goodwill

$2.9 m$2.9 m$2.9 m$2.9 m

Total Assets

$31 m$59.4 m$42.3 m$41.9 m

Accounts Payable

$8.6 m$8.4 m$6 m$9.1 m

Current Liabilities

$21.9 m$16.2 m$15.1 m$18 m

Additional Paid-in Capital

$148.9 m$185.2 m$188.6 m$201.2 m

Retained Earnings

($123.8 m)($142.7 m)($163 m)($178.3 m)

Total Equity

$42.1 m$24.9 m$22.1 m

Financial Leverage

1.4 x1.7 x1.9 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($11.5 m)($18.9 m)($20.3 m)($15.4 m)

Depreciation and Amortization

$601 k$696 k$880 k$1 m

Accounts Receivable

$264 k$826 k($52 k)($644 k)

Inventories

$56 k($21 k)($65 k)$79 k

Accounts Payable

Cash From Operating Activities

($1.1 m)

Purchases of PP&E

($198 k)($1.4 m)

Cash From Investing Activities

($685 k)($197 k)($1.8 m)($1.4 m)

Interest Paid

$220 k$148 k$4 k$4 k

Income Taxes Paid

$47 k$52 k$57 k$76 k

Biolase Market Value History

Biolase Online Presence

Biolase Company Life

You may also be interested in